Combination of Radiation Therapy with Novel Therapies

 

Chairs: 

• Corinne Faivre-Finn,  Radiation Oncologist, The Christie NHS Foundation Trust, United Kingdom
• Dirk de Ruysscher, Radiation Oncologist, Maastro, The Netherlands

 

Speakers: 

To be confirmed

 

Target Audience

Clinicians radiation oncologists/clinical oncologists/ medical oncologist/, early-career professionals, researchers interested in drug-RT combinations

 

Objectives:

• Facilitate the development of high-quality clinical trials combining radiotherapy with immunotherapy and targeted therapies.
• Support early-career researchers researchers in designing innovative trials with mentorship and industry collaboration.
• Strengthen collaboration between academia, industry, and clinical researchers for successful trial development.

 

Disease sites of interest

• Lung
• GI
• GU (bladder)

 

Potential Outcomes

• Refined, high quality trial proposals with expert and industry feedback
• Enhanced collaboration between early-career investigators, experienced mentors, and industry partners
• Clear pathways for further development, funding, and implementation of selected trials